Foster & Motley Inc. Purchases New Holdings in Intuitive Surgical, Inc. $ISRG

Foster & Motley Inc. acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, Holdings Channel reports. The firm acquired 1,448 shares of the medical equipment provider’s stock, valued at approximately $576,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Paladin Partners LLC acquired a new stake in Intuitive Surgical during the 2nd quarter valued at $566,000. Trust Co. of Vermont acquired a new stake in shares of Intuitive Surgical in the second quarter worth $1,680,000. Hikari Power Ltd acquired a new stake in shares of Intuitive Surgical in the second quarter worth $5,619,000. Plato Investment Management Ltd purchased a new position in shares of Intuitive Surgical during the second quarter valued at $4,315,000. Finally, J.Safra Asset Management Corp purchased a new position in shares of Intuitive Surgical during the second quarter valued at $58,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Oppenheimer upgraded Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 target price on the stock in a report on Wednesday, August 12th. Stifel Nicolaus decreased their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. Royal Bank Of Canada lowered their price objective on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research report on Monday, July 13th. Finally, Robert W. Baird cut their target price on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $508.68.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical is expanding its Asia-Pacific manufacturing footprint with a new plant in Penang, Malaysia. The facility is expected to increase production capacity and support regional demand for robotic-assisted surgery, reinforcing the company’s long-term growth strategy. Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific
• Positive Sentiment: Analysts highlighted the growing importance of ISRG’s software strategy. New da Vinci 5 features, software renewals and service-related recurring revenue could deepen customer relationships, improve revenue visibility and make the digital ecosystem an increasingly important growth driver alongside robot sales. Is ISRG’s Software Strategy Becoming as Important as Its Robots?
• Neutral Sentiment: A comparison with Abbott Laboratories noted that Abbott’s consistent recent growth and raised outlook may appeal to investors seeking steadier performance, while Intuitive Surgical offers higher-quality, premium growth potential. The comparison does not indicate a change in ISRG’s fundamentals but underscores valuation and execution expectations. Abbott vs. Intuitive Surgical: Is Consistent Growth Better Than Premium Growth?
• Negative Sentiment: Recent coverage said investors are reassessing Intuitive Surgical’s long-term growth prospects after its latest earnings, contributing to a major annual sell-off. The concern is that procedure-volume growth and future expansion may not justify ISRG’s still-premium valuation. Intuitive Surgical Stock Is Having Its Worst Year Since 2008
• Negative Sentiment: Executive Vice President Mark Brosius sold shares in two transactions under a pre-arranged Rule 10b5-1 trading plan. The sales modestly reduced his holdings, but the scheduled nature of the transactions makes them a limited signal of insider sentiment. SEC insider transaction filing

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares in the company, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the sale, the director owned 251 shares of the company’s stock, valued at $95,129. This represents a 61.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,224 shares of company stock worth $6,994,426 over the last quarter. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $397.72 on Thursday. The business has a 50 day simple moving average of $389.89 and a 200 day simple moving average of $438.02. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The stock has a market cap of $140.51 billion, a price-to-earnings ratio of 45.56, a PEG ratio of 2.83 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.